Portal Biotechnologies
PrivateLast Round
Early Funding
May 29, 2026
Total Funding Raised
$12M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Portal Biotechnologies is a biotechnology company that provides a cell engineering platform focused on intracellular delivery to accelerate advances enabled by RNA, gene editing, and AI-driven technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Portal Biotechnologies Comparables
Compare Portal Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kytopen | 86% | |
| MxT Biotech | 81% | |
| CellFE | 81% |
Portal Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 29, 2026 | ||||
| Seed | Dec 19, 2024 | ||||
| Pre Seed | Mar 19, 2024 |
Key People
Founding team and executive leadership
Portal Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TechU Ventures | Early Funding |
| NFX | Early Funding |
| 10X Capital | Pre Seed |
| Pear VC | Early Funding, Seed, Pre Seed |
| IA Ventures | Early Funding, Seed |
| Conscience VC | Pre Seed |
| Undeterred Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Grew 22% QoQ, from 88 to 107 employees.
- Aug 1, 2026
Grew 37% QoQ, from 71 to 97 employees.
Portal Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Portal Biotechnologies's valuation, stock price, and market status.
Is Portal Biotechnologies a public or private company?
Portal Biotechnologies is a private company.
What is the current stock price of Portal Biotechnologies?
Portal Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Portal Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Portal Biotechnologies worth (valuation)?
Valuation information for Portal Biotechnologies is not publicly available.
Can I buy Portal Biotechnologies stock?
Portal Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Portal Biotechnologies's last funding round?
Portal Biotechnologies's most recent funding round was Early Funding on May 29, 2026.
Who are the main investors in Portal Biotechnologies?
Key investors in Portal Biotechnologies include NFX, Pear VC, IA Ventures.
Will Portal Biotechnologies IPO soon?
No public IPO plans have been announced for Portal Biotechnologies.
How can I track Portal Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Portal Biotechnologies's shares on secondary markets.